Parmax Pharma Ltd.
| BSE: 540359 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE240T01014 |
| BSE 12:52 | 05 Jul | 32.70 |
-0.30 (-0.91%) |
OPEN
29.00 |
HIGH
32.70 |
LOW
28.05 |
| NSE 05:30 | 01 Jan | Parmax Pharma Ltd |
| OPEN | 29.00 |
| PREVIOUS CLOSE | 33.00 |
| VOLUME | 856 |
| 52-Week high | 70.90 |
| 52-Week low | 26.35 |
| P/E | 86.05 |
| Mkt Cap.(Rs cr) | 12 |
| Buy Price | 30.90 |
| Buy Qty | 220.00 |
| Sell Price | 32.00 |
| Sell Qty | 5.00 |
Parmax Pharma Ltd. (PARMAXPHARMA) - Company Information
Parmax Pharma Ltd
Incorporated as a public limited company in Nov.'94 Parmax Pharma (PPL) was promoted by Jayantilal S Dhol Purushottam J Bhalodi and Prabhudas D Hansalpara.PPL set up a plant to manufacture and market bulk drugs like amoxycillin tri-hydrate ampicillin tri-hydrate cephalexin mono hydrate and nalidixic acid at Hadamtala Gujarat with an installed capacity of 96 tpa.Its Antibiotic project has been full...> More
| COMPANY INFORMATION | |||||||
| Managing Director : | Umang Alkesh Gosalia | ||||||
| Non-Exec. & Independent Dir. : | Pramay Amritlal Chhatra | ||||||
| Non-Exec. & Independent Dir. : | Ami R Shah | ||||||
| Company Secretary : | Yash Vora | ||||||
| AUDITOR : | B A Shah/S R Mehta & Co | ||||||
| IND NAME : | Pharmaceuticals - Indian - Bulk Drugs | ||||||
| HOUSE NAME : | Indian Private | ||||||
| Registered office | |||||||
| Plot No 20 Survey No 52, Tal Kotda Sangani Hadamtala,Rajkot,Gujarat-360311 | |||||||
| Ph : 91-2827-270534/535 | |||||||
| WEBSITE : http://www.parmaxpharma.com | |||||||
| E-mail : info@parmaxpharma.com | |||||||
Quick Links for Parmax Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
